Target intelligence / Profile preview

Apoptosis inhibitor 5 pseudogene 1 (API5P1)

Target
API5P1
Molecular classification
Other (Pseudogene)
01

Overview

Apoptosis inhibitor 5 pseudogene 1 (API5P1) is classified as a pseudogene in the human genome, meaning that it is homologous to a functional gene (in this case, API5) but does not encode a functional protein itself[7][1][5]. Pseudogenes can arise through gene duplication or retrotransposition events and typically lack biological activity. API5P1 is listed as a pseudogene by several authoritative resources, including the HUGO Gene Nomenclature Committee (HGNC), and has the locus type "pseudogene"[7]. There is no evidence that API5P1 plays a direct role in disease, is druggable, or acts as a receptor, enzyme, transcription factor, or other conventional molecular target in therapeutic contexts. Important Distinction: Confusion may arise because the functional gene API5 (Apoptosis inhibitor 5) is a protein-coding gene involved in apoptosis inhibition and associated with certain cancers[8][2][3]. However, API5P1 refers specifically to the non-functional pseudogene copy, and not to the active therapeutic target API5. For drug discovery or mechanistic biology interests, refer to "Apoptosis inhibitor 5" (API5), not API5P1.

Other names
API5L1Apoptosis inhibitor 5 pseudogene 1

Beyond the preview

Go deeper on Apoptosis inhibitor 5 pseudogene 1 (API5P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apoptosis inhibitor 5 pseudogene 1 (API5P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call